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Ste11 is the mitogen-activated protein kinase (MAPK) kinase kinase
in the MAPK cascades that mediate mating, high osmolarity glyc-
erol, and filamentous growth responses in Saccharomyces cerevi-
siae. We show stimulation of the mating pathway by pheromone
promotes an accelerated turnover of Ste11 through a MAPK
feedback and ubiquitin-dependent mechanism. This degradation is
pathway specific, because Ste11 is stable during activation of the
high osmolarity glycerol pathway. Because the steady-state
amount of Ste11 does not change significantly during pheromone
induction, we infer that maintenance of MAPK activation involves
repeated cycles in which naı̈ve Ste11 is activated and then targeted
for degradation. This model predicts that elimination of active
Ste11 would rapidly curtail MAPK activation upon attenuation of
the upstream signal. This prediction is confirmed by the finding
that blocking ubiquitin-dependent Ste11 degradation during pher-
omone induction abolishes the characteristic attenuation profile
for MAPK activation.
A prevalent mechanism for intracellular signal transmissioninvolves three sequentially acting enzymes that function in
what is known as a mitogen-activated protein kinase (MAPK)
cascade. The prototype MAPK kinase kinase (MEKK) is the
yeast enzyme Ste11, which was identified for its role in phero-
mone-induced mating differentiation (1, 2). In the mating
MAPK cascade, Ste11 phosphorylates and activates the MAPK
kinase (MEK), Ste7, which in turn phosphorylates and activates
two MAPKs, Fus3 and Kss1 (3–7). Although Fus3 and Kss1
kinase activity is induced to an equivalent extent in pheromone-
treated cells, Fus3, but not Kss1, has specificity for critical
substrates that are dedicated to the mating differentiation re-
sponse (7). Ste11 also serves as the MEKK in two other
pathways, one that mediates responses to nutritional changes and
another that mediates responses to hyperosmotic stress. Nitro-
gen deprivation in diploid cells and glucose depletion in haploid
cells promote transitions to filamentous forms characteristic of
pseudohyphal and invasive growth in the respective cell types (8,
9). The cascade that mediates the transition to the filamentous
form in both cell types is made up of Ste11, Ste7, and Kss1
(10–13). The pathway that mediates the high osmolarity glycerol
(HOG) response has two branches. One branch responds to
activation of the Sln1-Ypd1-Skk1 two-component osmotic sen-
sor, whereas the other responds to activation of the Src homology
3-containing Sho1 membrane protein (14–16). Ssk2 and Ssk22
are redundant MEKKs in the Sln1 branch, and Ste11 is the
MEKK in the Sho1 branch. Ssk222 and Ste11 activate the MEK
Pbs2, which in turn activates the MAPK Hog1 (16, 17).
Even though Ste11 is a component of three separate pathways
(mating, filamentation, and osmotic stress) the stimulus of one
pathway elicits the appropriate response without spuriously
activating other Ste11-dependent outputs. For example, hyper-
osmolarity stimulates the HOG response without inducing mat-
ing differentiation (16). This biological specificity is caused, at
least in part, by the physical association of Ste11 with compo-
nents of the different pathways (16, 18). In the mating pathway,
Ste11, Ste7, Fus3, and indirectly Kss1 are in a complex with the
scaffold Ste5 (7, 19, 20). In the HOG pathway, the MAPK kinase
Pbs2 functions as a scaffold through its interactions with Ste11,
Hog1, and the membrane protein Sho1 (16). These different
assemblies are thought to poise Ste11 for activation by the
stimulus of a given pathway and therefore restrict the input signal
to activation of a single MAPK cascade. We reasoned that
different assemblies might also impose different modes of reg-
ulation on Ste11 in each of its pathways. This view prompted us
to examine more closely the regulation of Ste11 during phero-
mone-induced signaling and to test whether the same regulatory
mechanisms were common to its function in the HOG response
pathway.
Materials and Methods
Yeast Genetic Procedures and Strains. Unless otherwise specified,
yeast growth media and genetic manipulations were used as
described by Sherman et al. (21). Yeast strains were transformed
by the method of Ito et al. (22). For the construction of strains
with various deletions, we used the replacement method of
Rothstein (23). Gene replacements were confirmed either by
Southern blot or PCR analysis.
Yeast strains C699 –1 (ste11::URA3) and C699 –5
(bar1::HisG) were derived from strain C699 (MATa ade2–1
can1–100 his3–12, 16 leu2–3, 112 trp1–1 ura3–1) by gene replace-
ment (strain C699 is isogenic to strain W303–1A). An XbaI
fragment from plasmid pNC202 carries the ste11::URA3 allele
that was used for replacement at the STE11 locus (2). An
EcoRI–SalI fragment from plasmid C1329 (provided by K.
Nasmyth, Institute for Molecular Pathology, Vienna) carries the
bar1::HisG-URA3-HisG allele that was used for replacement at
the BAR1 locus. The bar1::HisG allele was generated from the
resulting strain by selection on 5-fluororotic acid medium (24).
This medium provides a positive selection for isolates in which
the URA3 marker is excised by recombination within the direct
HisG repeats (25). Strain C699 –15 (bar1::HisG
FUS1-lacZ::LEU2) was derived from strain C699–5 by integra-
tion of pNC296 at the LEU2 locus (6). C699–75 (bar1::HisG
FUS1-lacZ::LEU2 fus3::ADE2, kss1::URA3) was derived
from strain C699–15 by replacement of the FUS3 locus with a
BamHI–SalI fragment from pSL2223 carrying the fus3::ADE2
allele and the KSS1 locus using an EcoRI–SphI fragment from
pBC65 carrying the kss1::URA3 allele (20, 26). Strain E929–6C
(MATa cyc1 CYC7-H2 can1leu2–3, 112 trp1 1 ura3–52) and
strain FP50 (MATa ssk2::LEU2 ssk22::LEU2 ste11::HIS3 ura3
leu2 his3), which retains the function of only the Sho1- and
Ste11-dependent branch of the osmotic response pathway, have
been described (6, 16).
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Recombinant DNA Procedures and Plasmids. Bacterial transforma-
tions, bacterial DNA preparations, plasmid constructions, and
DNA restriction enzyme digestions were performed by standard
methods (27). pNC245 (GAL-STE11M CEN3 TRP1) and
pNC734 (GAL-STE11M CEN4 URA3) are plasmids that allow
galactose-dependent expression of a Ste11 derivative with a
C-terminal fusion to an 11-aa myc epitope. Construction of
pNC245 has been described (2). pNC734 carries the same
GAL-STE11M allele in the YCp50 (CEN4 URA3) vector (28).
YEpdoa4C571S (URA3) is a 2-m-based plasmid allowing ex-
pression of the dominant negative doa4C571S allele (29).
pGA1903 (TPI1-FUS3M CEN3 TRP1) was used for constitutive
expression of myc epitope-tagged Fus3 (Fus3M) (6).
Ste11 Protein Stability Determinations. Cultures were grown to
early log phase (1–2  107 cellsml) in the appropriate selective
medium containing 2% galactose for expression of GAL-
STE11M. Cells were harvested, washed, and switched to medium
containing 2% dextrose to inhibit further GAL-STE11M tran-
scription. After removal of initial samples for protein extract
preparation (time 0), incubation of the cultures continued
without or with pheromone (50 nM -factor) for induction of the
mating pathway activation cascade or with 0.4 M NaCl for
induction of the HOG cascade. Whole-cell protein extracts were
prepared for immune blot analysis either by the method of
Mattison et al. (30) or by a modified Pfiefer et al. (31) procedure
in which the ammonium sulfate fractionation step was omitted.
Immune Blot Analysis. Whole-cell protein extracts (100 g) were
fractionated by using 10% SDSPAGE. The 9E10 anti-myc
mAbs were used at 10 gml to detect Ste11M or Fus3M (2, 32).
Antitubulin mAbs were used at 0.17 gml to detect the
constitutively expressed Tub1 reference protein (Accurate
Chemicals). Goat anti-mouse IgG conjugated to alkaline phos-
phatase (0.17 gml) was used as the secondary antibody for
colorimetric detection with the Promega Protoblot immuno blot
system. Quantification of protein signals on immune blot images
was accomplished by using Scion IMAGE 1.60c software.
Immune Precipitation Kinase Assay. The Fus3M Doa4 (E929–6C
pGA1903) and Fus3M Doa4C571S (E929 – 6C pGA1903
YEpdoa4C571S) strains were grown in appropriate selective
medium to a density of 1  107 cellsml. Mating pheromone
-factor was added to a final concentration of 3 M. Extracts
from samples were prepared at the indicated times for immune
complex kinase assays as described by Errede et al. (3). The same
extract preparations were used for Fus3M immune blot analysis
(see above). Immune complexes were isolated under conditions
where activities vs. immune complex (beads) are in the linear
range: 200 g of extract using 16 g anti-myc 9E10 antibodies,
25 l protein A Sepharose beads (Amersham Pharmacia).
Kinase assays with -32ATP (DuPont-NEN) and myelin basic
protein (MBP) as substrate were performed directly on the
washed immune complexes as described (3). Proteins in the
immune complex kinase reaction were fractionated by SDS
PAGE (12.5%), and the amount of 32P incorporated into MBP
was determined by PhosphorImage analysis (Molecular Dynam-
ics) of the dried gel.
Results
Pheromone Stimulation Decreases Ste11 Protein Stability. We com-
pared the half-life of Ste11 protein in unstimulated and phero-
mone-stimulated cells. To make this comparison, we used a
plasmid that expresses a myc epitope-tagged version of Ste11
(Ste11M) under control of the regulated GAL1,10 promoter (2).
A yeast strain with this allele was grown to early log phase under
conditions (galactose medium) that allowed transcription of
Ste11M. The culture was switched to medium (glucose medium)
that blocks further transcription of Ste11M. Concurrent with the
change in medium, one portion of the culture was induced with
mating pheromone and the other was maintained as a no
induction reference. Whole-cell protein extracts were prepared
from aliquots of the cultures at the indicated times after the shift,
and the amount of Ste11M protein that persisted in the samples
was assessed by immune blot analysis using anti-myc antibodies
(Fig. 1). The amount of Ste11M protein in each sample is
reported as the ratio of the signal for Ste11M to that for an
internal reference (Tub1). Because GAL-STE11 mRNA may
persist and continue to be translated, the protein half-lives
measured by this approach may be longer than what would be
measured for endogenous Ste11 in the absence of protein
synthesis. Nevertheless, the relative difference in the half-life in
unstimulated vs. stimulated cultures provides a reasonable in-
dicator of whether protein stability is being affected. This
analysis reveals that the Ste11 protein has a significantly shorter
half-life (t1/2  50 min) under pheromone-inducing conditions
compared with noninducing conditions (t1/2 200 min) (Fig. 1 A,
B, and D). For reference, we examined the amount of Ste11M in
cultures undergoing pheromone induction with galactose in the
medium so that transcription of GAL-STE11M continued (Fig.
1 C and D). Because the steady-state amount of Ste11M shows
little decrease during exposure to pheromone, we infer that new
protein synthesis offsets the loss caused by accelerated protein
turnover (see below).
A Feedback and Ubiquitin-Dependent Process Mediates the Phero-
mone-Induced Change in Ste11 Protein Half-Life. To confirm that the
apparent depletion of Ste11M in the absence of transcription was
caused by protein turnover and to test whether turnover was
mediated by an ubiquitin-dependent pathway, we used the
doa4-C571S active site mutation (29). Doa4 is a deubiquitinating
enzyme that recycles ubiquitin from both proteosome-bound
ubiquitinated intermediates and membrane proteins destined for
destruction in the vacuole (33–35). Expression of the doa4-C571S
mutation from a high-copy plasmid in wild-type cells inhibits
degradation of ubiquitin-dependent substrates, presumably by
competition with the normal Doa4 for binding to component(s)
of the proteolytic machinery (29).
In contrast to cultures undergoing pheromone induction in the
DOA4 reference strain, the half-life of Ste11M in the doa4-C571S
overexpressing strain was found to be 200 min, which is the
same or greater than that observed for Ste11M in the culture
without pheromone induction (Fig. 2 A, C, and D). This result
establishes that pheromone induction accelerates Ste11 degra-
dation through an ubiquitin-dependent mechanism. We have not
been successful at detecting Ste11-ubiquitin or any other ubiq-
uitin-conjugated proteins in yeast and therefore have not been
able to ascertain whether Ste11 is directly ubiquitinated.
The diminished stability of Ste11 under pheromone-inducing
conditions could be either a direct or indirect consequence of its
activation. One indirect mechanism might involve a feedback
loop that depends on Fus3 and Kss1. To test this possibility, the
above protocol was applied to determine the half-life of Ste11M
under pheromone-inducing conditions in an isogenic fus3kss1
strain. The Ste11 protein has the same or greater half-life in the
fus3kss1 strain undergoing pheromone induction as in the
wild-type strain without pheromone induction (Fig. 2 B–D). As
it was previously established that Ste11 is activated by phero-
mone in this strain background (6), the finding here eliminates
the possibility that degradation of Ste11 is caused merely by its
conversion to an active form. Instead, Ste11 degradation de-
pends on a feedback mechanism involving the MAPKs of this
pathway.
Ste11 Protein Stability Is Not Affected by Hyperosmotic Stress. To test
whether Ste11 is similarly regulated in the HOG pathway, we








used the above protocol to measure the half-life of Ste11M in
cultures undergoing high osmolarity (0.4 M NaCl) induction. In
contrast to pheromone stimulation, Ste11M half-life is as long or
longer than that observed in the absence of stimulation (Fig. 3).
O’Rourke and Herskowitz (36) reported a Hog1-dependent
feedback mechanism that normally down-regulates the Sho1
branch of the HOG pathway. Our result shows that target
selection andor the mode of inhibition associated with the
Hog1-dependent mechanism differs from that of the Fus3Kss1-
dependent mechanism. Further, this outcome establishes that
Ste11 is subject to different modes of regulation in the two
pathways.
Fig. 1. Pheromone induction accelerates degradation of Ste11. Represen-
tative immune blots showing the time-dependent amount of Ste11M (A–C
Upper) from extracts of a wild-type strain (C699–15 pNC734) without induc-
tion (A) and with pheromone induction (B and C). Extracts from cultures
switched to dextrose show the persistence of pre-existing Ste11M (A and B)
whereas those from cultures maintained in galactose show the steady-state
amount of Ste11M (C). The steady-state amount of tubulin (Tub1) in each
sample serves as an internal reference (A–C Lower). (D) Plots of the relative
amount of Ste11M (Ste11MTub1) vs. time from no induction dextrose (),
pheromone induction dextrose (■ ), and pheromone induction galactose (})
cultures. The amount of Ste11M at each time is the average density of the
Ste11M signal divided by the average density of the Tub1 signal. Relative
amounts at different times are normalized to the amount of Ste11M at t  0
for the corresponding time course. Values shown on the plots are the average
from three or more independent experiments. Bars show the average devia-
tion for each point.
Fig. 2. Pheromone-induced degradation of Ste11 occurs through a MAPK
feedback and ubiquitin-dependent mechanism. Representative immune blots
showing the time-dependent decrease in pre-existing Ste11M (A–C Upper)
from extracts of a wild-type strain (C699–15 pNC245) without pheromone
induction (C), the same strain overexpressing the dominant negative doa4-
C571S allele (C699–15 pNC245 YEpdoa4C571S) during pheromone induction
(A) and an isogenic fus3kss1 strain (C699–75 pNC245) during pheromone
induction (B). The steady-state amount of tubulin (Tub1) in each sample serves
as an internal reference (A–C Lower). (D) Plots of the relative amount of
Ste11M (Ste11MTub1) vs. time from wild type no pheromone (), doa4-C571S
with pheromone (Œ), and fus3kss1 with pheromone (F) strains. Determi-
nation of the relative amount of Ste11 at each time point is as described in Fig.
1. Values are the average from three independent experiments. Bars show the
average deviation for each point.
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Ubiquitin-Dependent Degradation Contributes to Attenuation of
MAPK Activation in Response to Pheromone. The responsiveness of
cells to persistent pheromone induction diminishes with time.
This phenomenon occurs through several desensitization or
adaptation mechanisms that impinge on different components of
the signaling pathway (37–45). The feedback and ubiquitin-
dependent degradation of Ste11 could be an additional mech-
anism that contributes to desensitization. If this is the case, the
absence of ubiquitin-dependent degradation should compromise
normal signal attenuation and might even increase the signal
intensity because the active pool of Ste11 is not eliminated.
To test this prediction, we compared the Fus3 activation
profile for DOA4 cells where Ste11 turnover occurs to that for
doa4-C571S cells, where Ste11 is stable. To allow measurement of
Fus3 kinase activity by immune complex assays, the DOA4 and
doa4C571S strains expressed a myc epitope-tagged version of
Fus3 (Fus3M) from the constitutive TPI1 promoter (6). Protein
extracts were prepared from samples before pheromone addition
(t  0) and at the indicated times during pheromone induction.
The amount of Fus3M present in each extract was assessed by
immune blot analysis using anti-myc antibodies and was found to
remain constant throughout the time course in both DOA4 and
doa4C571S strain backgrounds (Fig. 4 A and B Lower). Immune
complex kinase assays were performed with each extract by using
MBP as substrate. Fus3 activity during pheromone induction in
the DOA4 background showed the typical time-course profile
(Fig. 4 A Upper and C). During the first 15–30 min of exposure
to pheromone, Fus3 activity increases 5-fold relative to the
unstimulated culture. This increase in activity then declines
during adaptation to the persistent stimulus. By contrast, more
active Fus3 accumulated in the doa4-C571S background (7- to
10-fold) during the initial phase of the induction profile and, as
predicted, the active pool, which persists in this background,
delayed or prevented the adaptation phase of Fus3 kinase
activation (Fig. 4 B Upper and C).
Discussion
The feedback-dependent regulation of Ste11 turnover during
pheromone induction suggests that the active pool of Ste11 is
preferentially targeted for ubiquitin-mediated degradation. The
question then arises as to how signal output is sustained during
Fig. 3. Osmotic induction does not accelerate Ste11 degradation. Represen-
tative immune blots showing the time-dependent decrease in pre-existing
Ste11M (A and B Upper) from extracts of a ssk2 ssk22 strain (FP50 pNC734)
without (A) or with osmotic induction (B). The steady-state amount of Tub1 in
each sample serves as an internal reference (A and B). (C) Plots of the relative
amount of Ste11M (Ste11MTub1) vs. time from the no induction (open
symbols) and 0.4 M NaCl induction (closed symbols) time courses. Determina-
tion of the relative amount of Ste11 at each time point is as described in Fig.
1. Values are the average from three independent experiments. Bars show the
average deviation for each point.
Fig. 4. Ubiquitin-dependent degradation is required for down-regulation of
MAPK activity during the adaptive response to pheromone. Representative
PhosphorImage of 32P incorporation into MBP (A and B Upper) from Fus3M
immune complex kinase assays and immune blots of Fus3M (A and B Lower)
by using extracts from (A) a DOA4 strain (E929–6C pGA1903) and (B) a
doa4C571S (E929–6C pGA1903 YEpdoa4C571S) strain during a pheromone
induction time course. (C) Plots of pheromone-induced Fus3 activation in
DOA4 (F) and doa4C571S (Œ) strains. Activities are determined from Phospho-
rImage quantification of 32P incorporation into MBP. Fus3 activation is in
arbitrary units relative to the average value obtained for Fus3 immune com-
plex assays using extracts isolated from the respective DOA4 and doa4C571S
strain extracts at t  0 min. Plot shows the average from four assays using
extracts from three independent time courses. Bars show the average devia-
tion for each point.








the time typically required for mating differentiation and cell
fusion (90 min). One mechanism to meet this requirement
could involve a cycle involving activation of Ste11 from a ‘‘naı̈ve’’
pool that is constantly replenished with newly synthesized pro-
tein (Fig. 5). In this cycle, Ste5 binds inactive Ste11 and takes it
to the plasma membrane for phosphorylation and activation by
Ste20 (46, 47). The active Ste11 continues the phosphorylation
cascade, leading to MAPK activation (3, 4). Once activated,
Fus3Kss1 then directly or indirectly promotes the rapid ubiq-
uitin-dependent degradation of active Ste11. This model is
consistent with the failure of van Drogen et al. (48) to detect a
functional Ste11–green fluorescent protein fusion at the tip of
mating projections where other components of the activation
cascade were observed to accumulate during pheromone induc-
tion. Because protein phosphorylation is often a prerequisite for
ubiquitination, it is plausible that Fus3Kss1 directly phosphor-
ylate Ste11 and that this modification within the complex at the
plasma membrane targets Ste11 for degradation. The possibility
of direct feedback phosphorylation seems reasonable because
Fus3 (or Kss1) feedback phosphorylates other components of
the cascade (3, 49, 50). Although seemingly wasteful, the cycle
of synthesis and degradation would impart high signal-to-noise
characteristics to the cascade and possibly contribute to the
specificity of signal output.
Another aspect of the above model is that ubiquitin-
dependent Ste11 degradation provides an inherent brake to the
pathway that can stop the activation cascade immediately upon
attenuation of the upstream signal. Our comparison of Fus3
activation profiles in the wild-type and doa4C571S strains estab-
lishes that ubiquitin-dependent degradation is necessary for
attenuation (Fig. 4). The accumulation of an active pool of Ste11
in the doa4C571S background would counter the inactivation of
Fus3 by the Msg5 dual-specificity phosphatase and explain
abolishment of the characteristic attenuation profile (44). The
only other components upstream of Fus3 in the pathway that are
known to undergo ubiquitin-dependent degradation are the
receptor and the G subunit (41, 51). Although the doa4C571S
background used here would also stabilize these two upstream
components, their stabilization would not abolish adaptation. G
protein activation is down-regulated by receptor phosphoryla-
tion, a mechanism that is independent of ubiquitin-mediated
degradation (40). Therefore, desensitization to pheromone still
occurs with respect to G protein activation. Further, a lysine to
arginine substitution mutation in G-Gpa1 that prevents its
ubiquitin-dependent degradation causes an enhanced adapta-
tion response (52). It remains possible that other components of
the pathway upstream from Fus3 might be subject to ubiquitin-
dependent degradation and would also contribute to attenuation
of Fus3 activation. We have previously shown that Ste7 protein
persists during pheromone induction in the absence of protein
synthesis (6) and thus is unlikely to contribute to attenuation by
this mechanism. Further, the observations of van Drogen et al.
(48) concerning Ste5, Ste11, Ste7, and Fus3 localization and
persistence during pheromone induction suggest that Ste11
indeed may be the component of the activation cascade that is
most acutely affected by ubiquitin-dependent degradation. This
view argues that persistence of Ste11 is likely to be primarily
responsible for abrogation of the MAPK attenuation profile that
we observed in our analysis.
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